AKBA · Akebia Therapeutics, Inc. · Documents
$0.62
-0.06 (-8.56%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$177.65M
Shares
277.11M
Volume · Oct 20
9.99M
Avg daily vol (3M)
6.83M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-04-23 | 2024-04-17 | |
| 8-K | — | 2024-04-16 | 2024-04-15 | |
| 8-K | — | 2024-03-28 | 2024-03-27 | |
| 8-K | — | 2024-03-15 | — | |
| 10-K | — | 2024-03-14 | 2023-12-31 | |
| 8-K | — | 2024-03-14 | — | |
| 8-K | — | 2024-02-13 | 2024-02-08 | |
| 8-K | — | 2024-01-30 | 2024-01-29 | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-18 | 2023-12-14 | |
| 8-K | — | 2023-11-21 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-11-02 | 2023-10-31 | |
| 8-K | — | 2023-10-25 | — | |
| 8-K | — | 2023-10-12 | 2023-10-06 | |
| 8-K | — | 2023-09-26 | — | |
| 10-K/A | — | 2023-08-28 | 2022-12-31 | |
| 10-Q | — | 2023-08-28 | 2023-06-30 | |
| 8-K | — | 2023-08-25 | — | |
| 8-K | — | 2023-08-17 | 2023-08-11 | |
| 8-K | — | 2023-08-11 | 2023-08-10 | |
| NT 10-Q | — | 2023-08-10 | — | |
| 8-K | — | 2023-08-01 | 2023-07-26 | |
| 8-K | — | 2023-07-18 | — | |
| 8-K | — | 2023-06-13 | 2023-06-09 | |
| 8-K | — | 2023-06-08 | 2023-06-06 | |
| 8-K | — | 2023-06-07 | — | |
| 8-K | — | 2023-06-02 | 2023-05-30 | |
| 8-K | — | 2023-05-31 | 2023-05-26 | |
| 8-K | — | 2023-05-30 | — | |
| 8-K | — | 2023-05-25 | 2023-05-24 | |
| 8-K | — | 2023-05-23 | 2023-05-22 | |
| 8-K | — | 2023-05-09 | — | |
| 8-K | — | 2023-05-08 | — | |
| 8-K | — | 2023-05-08 | 2023-05-04 | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| ARS | — | 2023-04-28 | 2022-12-31 | |
| 8-K | — | 2023-04-28 | 2023-04-27 | |
| DEF 14A | — | 2023-04-28 | — | |
| 8-K | — | 2023-04-25 | — | |
| DEFA14A | — | 2023-04-21 | — | |
| DEFA14A | — | 2023-04-14 | — | |
| DEFA14A | — | 2023-04-14 | — | |
| 8-K | — | 2023-04-11 | — | |
| DEFA14A | — | 2023-04-11 | — | |
| DEFA14A | — | 2023-03-31 | — | |
| DEFA14A | — | 2023-03-27 | — | |
| DEFA14A | — | 2023-03-27 | — |
Showing 51–100 of 181 filings
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
17 filings
17 filers
Visit website
Investor relations